Wishing all the best to Abhijith Biji as he moves to join Microbio PhD program in the Icahn School of Medicine at Mount Sinai, New York. As first undergrad student, he has set the bar high and we were lucky to have him in the lab. I know he is going to accomllish great feats and make us proud.

Work done by Rishad in the lab.

Congratulations Rishad

Glad to have contributed to this study Science Advances. It describes host factors that restrict or facilitate Flu infections across different hosts. Thanks to DBT/WT India Alliance for supporting Emerging Viral Pathogens Lab, CIDR, IISc . science.org/doi/10.1126/sc…

GO VIRAL🦠🔬with the Chanda Lab !!! Check out this RESEARCH ASSISTANT II, (Virology, Immunology)- recruiting2.ultipro.com/SCR1003TSRI/Jo… #virology #scrippsjobs Sumit Chanda

Misty morning in IISc Campus

Transitioning from post doc to professor

Recombination mutation is on the rise in the SARS-CoV-2 virus. Shashank Tripathi is investigating the reasons behind this rise of recombinants Shaastra Magazine, IIT Madras shaastramag.iitm.ac.in/special-featur…

Our research article reporting enhanced recombination in SARS-CoV-2 Omicron variants, its potential cause and consequences is now published in the Journal of Medical Virology. Full credit to Rishad in our lab. onlinelibrary.wiley.com/doi/10.1002/jm…

Very Busy ‘Open Day 2023’ for Emerging Viral Pathogens Lab, CIDR, IISc lab at CIDR, IISc

Coverage of recent research from ⁦Emerging Viral Pathogens Lab, CIDR, IISc⁩ m.timesofindia.com/india/enhanced…

New study by Emerging Viral Pathogens Lab, CIDR, IISc Shashank Tripathi shows how several mutations accumulated through recombination in #SARSCoV2 viral proteins, allows the Omicron variants to escape from the host’s defenses and bind more tightly to the host cell. iisc.ac.in/events/enhance… #IIScresearch

Trying On new Lab T-Shirt, designed by lab colleagues.

Online now: Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo dlvr.it/SsKT18

Glad to share this study on broad spectrum antiviral, led by Rohan Narayan in ⁦⁦Emerging Viral Pathogens Lab, CIDR, IISc⁩, now published in Cell Reports Medicine. Thanks to ⁦DBT-BIRAC⁩ and ⁦DBT/WT India Alliance⁩ for funding. cell.com/cell-reports-m…

We have extended the registration deadline to 25th August. Abstract submission is mandatory fro registration. For more details visit molecularvirology2023.wordpress.com

#Molecular Virology 2023 at @IISc: 2 days of high-quality Virology, sourced from about 50 institutions across India. Congratulations to all the winners. Thanks to all the participants and sponsors. DBT/WT India Alliance @JNCASR DBT-THSTI . The next one in IAV TVM, Kerala.

Pleased to share this study from Emerging Viral Pathogens Lab, CIDR, IISc on innate immune antagonism by SARS-CoV-2. Published in Cellular And Molecular Life Sciences Springer Cell Bio. Kudos to OYAHIDA KHATUN leading this. link.springer.com/article/10.100…

Members of Emerging Viral Pathogens Lab, CIDR, IISc are glad to be part of the upcoming GLOBAL-BIO INDIA 2023 meet in Pragati Maidan, New Delhi, from December 4-6th 2023. Looking forward to meeting startups, Pharma companies, and researchers at our stall (Booth No. F77)DBT-BIRAC

Today marks 5 years of Emerging Viral Pathogens Lab, CIDR, IISc Lab. We have done alright so far. Looking forward to more exciting science in the next 5.